SEC Comment Letter for Inotiv, Inc. (NOTV) (CIK 0000720154) (NOTV) — May 22, 2012
Inotiv, Inc. (NOTV) (CIK 0000720154)
Date: May 22, 2012 · CIK: 0000720154 · Accession: 0000000000-12-026410
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-23357
Letter
May 22, 2012 Via E-mail Anthony S. Chilton President and Chief Executive Officer Bioanalytical Systems, Inc. 2701 Kent Avenue West Lafayette, Indiana 47906 Re: Bioanalytical Systems, Inc. Form 10-K Filed December 29, 2011 File No. 000-23357
Dear Mr. Chilton: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,
/s/ Jennifer Riegel for Jeffrey Riedler Assistant Director cc: Stephen J. Hackman Ice Miller LLP One American Square, Suite 2900 Indianapolis, IN 46282
Show Raw Text
May 22, 2012 Via E-mail Anthony S. Chilton President and Chief Executive Officer Bioanalytical Systems, Inc. 2701 Kent Avenue West Lafayette, Indiana 47906 Re: Bioanalytical Systems, Inc. Form 10-K Filed December 29, 2011 File No. 000-23357 Dear Mr. Chilton: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Jennifer Riegel for Jeffrey Riedler Assistant Director cc: Stephen J. Hackman Ice Miller LLP One American Square, Suite 2900 Indianapolis, IN 46282